A human monoclonal 1 antibody blocking SARS-CoV-2 infection
This is the paper submitted for review https://www.biorxiv.org/content/10.1101/2020.03.11.987958v1If it passesthe review stage it will probably be published in the scientific Journal Nature.Note: this is not a vaccine. Its a treatment option for people who are already sick.